CG Oncology Announces Key Executive Appointments in Commercialization, Medical and Manufacturing Operations by Carolyn Helms | Sep 5, 2023 | Portfolio News
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics by Carolyn Helms | Sep 5, 2023 | Portfolio News
Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb by Carolyn Helms | Sep 5, 2023 | Portfolio News
CG Oncology Announces $105 Million Oversubscribed Crossover Financing to Support Continued Advancement of Clinical-Stage Bladder Cancer Pipeline by Carolyn Helms | Aug 2, 2023 | Portfolio News
CG Oncology Announces $105 Million Oversubscribed Crossover Financing to Advance Clinical-Stage Bladder Cancer Pipeline by Carolyn Helms | Aug 2, 2023 | Uncategorized
